135 related articles for article (PubMed ID: 12853135)
1. Genomic definition of a pure intronic dystrophin deletion responsible for an XLDC splicing mutation: in vitro mimicking and antisense modulation of the splicing abnormality.
Gualandi F; Rimessi P; Cardazzo B; Toffolatti L; Dunckley MG; Calzolari E; Patarnello T; Muntoni F; Ferlini A
Gene; 2003 Jun; 311():25-33. PubMed ID: 12853135
[TBL] [Abstract][Full Text] [Related]
2. Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for x-linked dilated cardiomyopathy.
Rimessi P; Fabris M; Bovolenta M; Bassi E; Falzarano S; Gualandi F; Rapezzi C; Coccolo F; Perrone D; Medici A; Ferlini A
Hum Gene Ther; 2010 Sep; 21(9):1137-46. PubMed ID: 20486769
[TBL] [Abstract][Full Text] [Related]
3. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy.
Ferlini A; Galié N; Merlini L; Sewry C; Branzi A; Muntoni F
Am J Hum Genet; 1998 Aug; 63(2):436-46. PubMed ID: 9683584
[TBL] [Abstract][Full Text] [Related]
4. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
5. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy.
Milasin J; Muntoni F; Severini GM; Bartoloni L; Vatta M; Krajinovic M; Mateddu A; Angelini C; Camerini F; Falaschi A; Mestroni L; Giacca M
Hum Mol Genet; 1996 Jan; 5(1):73-9. PubMed ID: 8789442
[TBL] [Abstract][Full Text] [Related]
6. Genomic and transcription studies as diagnostic tools for a prenatal detection of X-linked dilated cardiomyopathy due to a dystrophin gene mutation.
Rimessi P; Gualandi F; Duprez L; Spitali P; Neri M; Merlini L; Calzolari E; Muntoni F; Ferlini A
Am J Med Genet A; 2005 Feb; 132A(4):391-4. PubMed ID: 15641026
[TBL] [Abstract][Full Text] [Related]
7. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
Takeshima Y; Nishio H; Sakamoto H; Nakamura H; Matsuo M
J Clin Invest; 1995 Feb; 95(2):515-20. PubMed ID: 7860733
[TBL] [Abstract][Full Text] [Related]
8. Newly recognized exons induced by a splicing abnormality from an intronic mutation of the dystrophin gene resulting in Duchenne muscular dystrophy. Mutations in brief no. 213. Online.
Ikezawa M; Nishino I; Goto Y; Miike T; Nonaka I
Hum Mutat; 1999; 13(2):170. PubMed ID: 10094556
[TBL] [Abstract][Full Text] [Related]
9. A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution.
Dwi Pramono ZA; Takeshima Y; Surono A; Ishida T; Matsuo M
Biochem Biophys Res Commun; 2000 Jan; 267(1):321-8. PubMed ID: 10623618
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the 5'-UTR of retinal dystrophin reveals a cryptic intron that regulates translational activity.
Kubokawa I; Takeshima Y; Ota M; Enomoto M; Okizuka Y; Mori T; Nishimura N; Awano H; Yagi M; Matsuo M
Mol Vis; 2010 Dec; 16():2590-7. PubMed ID: 21151598
[TBL] [Abstract][Full Text] [Related]
11. Cryptic splice activation but not exon skipping is observed in minigene assays of dystrophin c.9361+1G>A mutation identified by NGS.
Niba ETE; Nishida A; Tran VK; Vu DC; Matsumoto M; Awano H; Lee T; Takeshima Y; Nishio H; Matsuo M
J Hum Genet; 2017 Apr; 62(5):531-537. PubMed ID: 28100912
[TBL] [Abstract][Full Text] [Related]
12. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
13. Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.
Zhang Z; Habara Y; Nishiyama A; Oyazato Y; Yagi M; Takeshima Y; Matsuo M
J Hum Genet; 2007; 52(7):607-617. PubMed ID: 17579806
[TBL] [Abstract][Full Text] [Related]
14. The 5' region of intron 11 of the dystrophin gene contains target sequences for mobile elements and three overlapping ORFs.
Ferlini A; Muntoni F
Biochem Biophys Res Commun; 1998 Jan; 242(2):401-6. PubMed ID: 9446807
[TBL] [Abstract][Full Text] [Related]
15. In vivo study of an aberrant dystrophin exon inclusion in X-linked dilated cardiomyopathy.
Cohen N; Rimessi P; Gualandi F; Ferlini A; Muntoni F
Biochem Biophys Res Commun; 2004 May; 317(4):1215-20. PubMed ID: 15094399
[TBL] [Abstract][Full Text] [Related]
16. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
[TBL] [Abstract][Full Text] [Related]
17. Intronic antisense Alu elements have a negative splicing effect on the inclusion of adjacent downstream exons.
Nakama M; Otsuka H; Ago Y; Sasai H; Abdelkreem E; Aoyama Y; Fukao T
Gene; 2018 Jul; 664():84-89. PubMed ID: 29698748
[TBL] [Abstract][Full Text] [Related]
18. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
Baskin B; Banwell B; Khater RA; Hawkins C; Ray PN
Neuromuscul Disord; 2009 Mar; 19(3):189-92. PubMed ID: 19230662
[TBL] [Abstract][Full Text] [Related]
19. Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.
Nishida A; Minegishi M; Takeuchi A; Awano H; Niba ET; Matsuo M
Hum Genet; 2015 Sep; 134(9):993-1001. PubMed ID: 26152642
[TBL] [Abstract][Full Text] [Related]
20. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.
Wilton SD; Lloyd F; Carville K; Fletcher S; Honeyman K; Agrawal S; Kole R
Neuromuscul Disord; 1999 Jul; 9(5):330-8. PubMed ID: 10407856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
